Citation Impact
Citing Papers
Accelerated telomere shortening in response to life stress
2004 StandoutNobel
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Myeloproliferative disorders: complications, survival and causes of death
2000
Nasopharyngeal carcinoma
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity
2009
Differential Inactivation of Caspase-8 in Lung Cancers
2002
Mitotic Checkpoint Inactivation Fosters Transformation in Cells Lacking the Breast Cancer Susceptibility Gene, Brca2
1999 StandoutNobel
Testicular Germ-Cell Cancer
1997 Standout
Thyroid cancer
2016 Standout
Anaplastic lymphoma kinase proteins in growth control and cancer
2004
Quantitative Analysis of Epstein‐Barr Virus DNA in Plasma and Serum
2001
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
The biology and function of fibroblasts in cancer
2016 Standout
Telomere states and cell fates
2000 StandoutNatureNobel
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Vascular disorders of the liver # †
2008 Standout
Telomere dysfunction and the initiation of genome instability
2003 StandoutNobel
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era
2002
High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.
1994
Expression of P-Glycoprotein in High-Grade Osteosarcomas in Relation to Clinical Outcome
1995
Control of apoptosis and mitotic spindle checkpoint by survivin
1998 StandoutNature
ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor
2001
Nasopharyngeal carcinoma
2015 Standout
Diabetes and Atherosclerosis
2002 Standout
Graft-versus-host disease
2009 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis
1997
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
1999 StandoutNobel
Apoptosis
2002 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma.
1996
Resistance in the anti-angiogenic era: nay-saying or a word of caution?
2003
Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas
1997
Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue
1992
Infectious agents and lymphoma development: molecular and clinical aspects
2009
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 Standout
Magnetic Drug Targeting--Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment
2003
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
MOLECULAR MECHANISMS OF ULTRAVIOLET RADIATION CARCINOGENESIS
1990
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Co-expression of Epstein-Barr virus latent membrane protein and vimentin in “aggressive” histological subtypes of Hodgkin's disease
1993
MCL-1 expression in B-cell non-Hodgkin’s lymphomas
2004
Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agents
1991
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Head and Neck Cancer
2001 Standout
The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field
1993
Epstein–Barr Virus Infection
2000 Standout
Genome-wide analysis of human global and transcription-coupled excision repair of UV damage at single-nucleotide resolution
2015 StandoutNobel
High-dose melphalan for multiple myeloma: long-term follow-up data.
1994
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Mitoxantrone, Etoposide, and Cytarabine With or Without Valspodar in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome: A Phase III Trial (E2995)
2004
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage.
1996
Tumour stem cells and drug resistance
2005 Standout
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Telomere length is paternally inherited and is associated with parental lifespan
2007 StandoutNobel
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes
1992
Redefining the Target: Chemotherapeutics as Antiangiogenics
2001
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
Electrochemiluminescence (ECL)
2004 Standout
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.
1999
Telomeres and telomerase
2004 StandoutNobel
A multidrug resistance transporter from human MCF-7 breast cancer cells
1998 Standout
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
1997
BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders [see comments]
1996
Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR
1999
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
2004
Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67Gallium Scan in 50 Patients
1999
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
1999
Modulation of tumor cell response to chemotherapy by the organ environment
1994
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells
1997
Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells
1997
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.
1991 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
1998 StandoutScience
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of D Schlaifer being referenced
bcl‐2 proto‐oncogene and Epstein–Barr virus latent membrane protein‐1 expression in AIDS‐related lymphoma
1994
Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers
1990
Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
1996
Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
1991
Primary Mediastinal Large B-Cell Lymphoma
1996
Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.
1994
High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease
1999
Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
1999
Telomerase Activity in Reactive and Neoplastic Lymphoid Tissues: Infrequent Detection of Activity in Hodgkin's Disease
1997
Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections [see comments]
1991
Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection.
1996
Asper gillose pulmonaire invasive suivie d'une spondylodiscite L1–L2 au cours du traitement d'induction d'une leucemie aigue lymphoblastique. Guerison par la triple association amphotericine b, 5-fluorocytosine, itraconazole et abord direct
1989
Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas.
1993
Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.
1991
Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
1989
High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease
1995
High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining
1996
B-cell lymphoma following polycythemia vera: evidence for the involvement of two different clones.
1994
Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial
1993
Telomerase Activity in Reactive and Neoplastic Lymphoid Tissues: Infrequent Detection of Activity in Hodgkin's Disease
1997